Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
The Oncologist
|
April 9, 2014
Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patients
Geetika Srivastava, Lindsay A Renfro, Robert J Behrens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 14, 2025
Molecular characterization of patients with metastatic invasive lobular carcinoma (ILC): using real-world data to describe this unique clinical entity
Andrew A Davis, Ellen Jaeger, Ian S Hagemann, et al.
Journal of the National Cancer Institute
|
March 15, 2026
Landscape of somatic genetic alterations and PAM50 intrinsic subtypes in breast cancer associated with germline pathogenic variants in DNA-repair genes
Siddhartha Yadav, Sonya Reid, Binyam Yilma, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 23, 2016
Impact of the 12-Gene Colon Cancer Assay on Clinical Decision Making for Adjuvant Therapy in Stage II Colon Cancer Patients
Baruch Brenner, Ravit Geva, Megan Rothney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2016
12-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study
Takeharu Yamanaka, Eiji Oki, Kentaro Yamazaki, et al.
Breast Cancer Research and Treatment
|
July 1, 2017
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial
Ulrike Nitz, Oleg Gluz, Matthias Christgen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 31, 2013
Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer
Vered Stearns, Lisa K Jacobs, Maryjo Fackler, et al.
Breast Cancer Research and Treatment
|
January 12, 2019
Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial
Ulrike Nitz, Oleg Gluz, Matthias Christgen, et al.
JCO Global Oncology
|
June 28, 2021
Substantial Reduction in Adjuvant Chemotherapy With the Use of the 21-Gene Test to Manage Early Breast Cancer in a Public Hospital in Brazil
André Mattar, Guilherme R Fonseca, Murilo B A Romão, et al.
Breast Cancer Research and Treatment
|
September 23, 2018
Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study
Hiroji Iwata, Norikazu Masuda, Yutaka Yamamoto, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
The Oncologist
|
April 9, 2014
Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patients
Geetika Srivastava, Lindsay A Renfro, Robert J Behrens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 14, 2025
Molecular characterization of patients with metastatic invasive lobular carcinoma (ILC): using real-world data to describe this unique clinical entity
Andrew A Davis, Ellen Jaeger, Ian S Hagemann, et al.
Journal of the National Cancer Institute
|
March 15, 2026
Landscape of somatic genetic alterations and PAM50 intrinsic subtypes in breast cancer associated with germline pathogenic variants in DNA-repair genes
Siddhartha Yadav, Sonya Reid, Binyam Yilma, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 23, 2016
Impact of the 12-Gene Colon Cancer Assay on Clinical Decision Making for Adjuvant Therapy in Stage II Colon Cancer Patients
Baruch Brenner, Ravit Geva, Megan Rothney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2016
12-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study
Takeharu Yamanaka, Eiji Oki, Kentaro Yamazaki, et al.
Breast Cancer Research and Treatment
|
July 1, 2017
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial
Ulrike Nitz, Oleg Gluz, Matthias Christgen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 31, 2013
Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer
Vered Stearns, Lisa K Jacobs, Maryjo Fackler, et al.
Breast Cancer Research and Treatment
|
January 12, 2019
Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial
Ulrike Nitz, Oleg Gluz, Matthias Christgen, et al.
JCO Global Oncology
|
June 28, 2021
Substantial Reduction in Adjuvant Chemotherapy With the Use of the 21-Gene Test to Manage Early Breast Cancer in a Public Hospital in Brazil
André Mattar, Guilherme R Fonseca, Murilo B A Romão, et al.
Breast Cancer Research and Treatment
|
September 23, 2018
Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study
Hiroji Iwata, Norikazu Masuda, Yutaka Yamamoto, et al.
Page
of 4